Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
Saved in:
| Title: | Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer? |
|---|---|
| Authors: | Godet Y; INSERM U1098; Unité Mixte de Recherche; Besançon, France ; Etablissement Français du Sang de Bourgogne Franche-Comté; Besançon, France ; Université de Franche-Comté; Besançon, France., Dosset M, Borg C, Adotevi O |
| Source: | Oncoimmunology [Oncoimmunology] 2012 Dec 01; Vol. 1 (9), pp. 1617-1619. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23264913 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Godet+Y%22">Godet Y</searchLink>; INSERM U1098; Unité Mixte de Recherche; Besançon, France ; Etablissement Français du Sang de Bourgogne Franche-Comté; Besançon, France ; Université de Franche-Comté; Besançon, France.<br /><searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink><br /><searchLink fieldCode="AU" term="%22Borg+C%22">Borg C</searchLink><br /><searchLink fieldCode="AU" term="%22Adotevi+O%22">Adotevi O</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2012 Dec 01; Vol. 1 (9), pp. 1617-1619. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23264913 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4161/onci.21513 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1617 Titles: – TitleFull: Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Godet Y – PersonEntity: Name: NameFull: Dosset M – PersonEntity: Name: NameFull: Borg C – PersonEntity: Name: NameFull: Adotevi O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2012 Dec 01 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 1 – Type: issue Value: 9 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |